Composition and method for modulating vasculogenesis or angiogenesis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20030211994A1
SERIAL NO

10303997

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for modulating vasculogenesis or angiogenesis using the core domain protein of PDGF-C, a new member of the PDGF/VEGF family of growth factors, or a homodimer or a heterodimer comprising the core domain. Also disclosed are pharmaceutical compositions comprising the core protein, nucleotide sequences encoding the protein, and uses thereof in medical and diagnostic applications.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGYRIJVISSCHESTRAAT 120 ZWIJNAARDE B-9052
LUDWIG INSTITUTE OF CANCER RESEARCH605 THIRD AVENUE NEW YORK NY 10158

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carmeliet, Peter Leuven, BE 50 274
Collen, Desire Leuven, BE 28 134
Eriksson, Ulf Stockholm, SE 86 482
Li, Xuri Stockholm, SE 19 62

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation